Explore more publications!
Iowa Healthcare Reporter
Got News to Share?

Iowa Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Iowa Healthcare Reporter.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on November 3, 2025

Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler
November 3, 2025

Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler

Indeterminate GlobeNewswire
Empowering Positive Community Impact Through Hockey, Dr. Oetker’s Giuseppe Pizzeria “Practice with a Pro” Contest Returns for the Fourth Year
November 3, 2025

Empowering Positive Community Impact Through Hockey, Dr. Oetker’s Giuseppe Pizzeria “Practice with a Pro” Contest Returns for the Fourth Year

Indeterminate GlobeNewswire
Tisento Therapeutics Announces Publication of MELAS Interview Study, Incorporating Patients’ Perspectives to Elucidate Symptoms and Impacts of Rare Mitochondrial Disease
November 3, 2025

Tisento Therapeutics Announces Publication of MELAS Interview Study, Incorporating Patients’ Perspectives to Elucidate Symptoms and Impacts of Rare Mitochondrial Disease

Indeterminate GlobeNewswire
Renforcer l’impact positif dans les communautés grâce au hockey : le concours « Entraînez-vous avec un pro » de Dr. Oetker - Giuseppe Pizzeria est de retour pour une 4e année
November 3, 2025

Renforcer l’impact positif dans les communautés grâce au hockey : le concours « Entraînez-vous avec un pro » de Dr. Oetker - Giuseppe Pizzeria est de retour pour une 4e année

Indeterminate GlobeNewswire
Krystal Biotech Announces Third Quarter 2025 Financial and Operating Results
November 3, 2025

Krystal Biotech Announces Third Quarter 2025 Financial and Operating Results

Indeterminate GlobeNewswire
Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell Therapies
November 3, 2025

Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell Therapies

Indeterminate GlobeNewswire
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
November 3, 2025

Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma
November 3, 2025

Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma

Indeterminate GlobeNewswire
Kamada to Announce Third Quarter and Nine Months Ended September 30, 2025 Financial Results on November 10, 2025
November 3, 2025

Kamada to Announce Third Quarter and Nine Months Ended September 30, 2025 Financial Results on November 10, 2025

Indeterminate GlobeNewswire
Jade Biosciences to Participate in Upcoming Conferences
November 3, 2025

Jade Biosciences to Participate in Upcoming Conferences

Indeterminate GlobeNewswire
Psyence BioMed Strengthens Strategic Partnership with PsyLabs Through USD $3,500,000 Follow-On Investment
November 3, 2025

Psyence BioMed Strengthens Strategic Partnership with PsyLabs Through USD $3,500,000 Follow-On Investment

Indeterminate GlobeNewswire
Kymera Therapeutics to Participate in Upcoming November Investor Conferences
November 3, 2025

Kymera Therapeutics to Participate in Upcoming November Investor Conferences

Indeterminate GlobeNewswire
TG Therapeutics Reports Third Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance
November 3, 2025

TG Therapeutics Reports Third Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance

Indeterminate GlobeNewswire
Multiple Myeloma Research Foundation Joins Forces with Patients and Caregivers for Road to Victories Fundraiser
November 3, 2025

Multiple Myeloma Research Foundation Joins Forces with Patients and Caregivers for Road to Victories Fundraiser

Indeterminate GlobeNewswire
Benitec Biopharma Announces Appointment of Sharon Mates Ph.D. to its Board of Directors
November 3, 2025

Benitec Biopharma Announces Appointment of Sharon Mates Ph.D. to its Board of Directors

Indeterminate GlobeNewswire
BioCryst Reports Third Quarter 2025 Financial Results and Provides Business Update
November 3, 2025

BioCryst Reports Third Quarter 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Iovance Biotherapeutics Reports Potential Best-in-Class Clinical Data for Lifileucel TIL Cell Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC)
November 3, 2025

Iovance Biotherapeutics Reports Potential Best-in-Class Clinical Data for Lifileucel TIL Cell Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC)

Indeterminate GlobeNewswire
Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results
November 3, 2025

Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
Conavi Expands Leadership Team to Support Next Phase of U.S. Commercialization
November 3, 2025

Conavi Expands Leadership Team to Support Next Phase of U.S. Commercialization

Indeterminate GlobeNewswire
Abpro Announces 1-for-30 Reverse Stock Split Effective November 3, 2025
November 3, 2025

Abpro Announces 1-for-30 Reverse Stock Split Effective November 3, 2025

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions